Moderna could tumble once again, if there's a lack of positive news in its upcoming earnings release. Novo Nordisk looks cheap, but the drugmaker's low valuation makes sense compared to future growth ...

Representatives from The Office for Women cannot recall any instance where a minister has asked them for feedback on third-party policy proposals on women’s issues. Coalition Senator Jane Hume asked ...